Specifica Is Pleased to Announce the United States Patent and Trademark Office Has Granted Two Patents to Specifica for Its Innovative Generation 3 Antibody Discovery Platform
Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the recent granting of two new patents by the United States Patent